UNIVERSAL HEALTH SERVICES, INC. financials

  1. Home
  2. Financials
  3. UHS
UHS CIK 0000352915

Source: EDGAR filings · Built 2026-06-02T04:16:10Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 846.88M 1.12B 520.92M 258.57M 25.19M 1.63B
EBITDA 2.61B 2.27B 1.74B 1.59B 1.90B 1.87B
Working Capital 168.31M 605.88M 798.00M 622.92M 279.45M 800.83M
Net Debt 5.17B 4.92B 5.32B 5.24B 4.52B 3.02B
Operating Margin 11.48% 10.63% 8.23% 7.49% 10.78% 11.75%
Net Margin 8.57% 7.22% 5.03% 5.04% 7.84% 8.17%
Return on Equity (ROE) 20.46% 17.13% 11.67% 11.41% 16.28% 14.94%
Return on Assets (ROA) 9.59% 7.89% 5.14% 5.01% 7.57% 7.00%
Current Ratio 1.05× 1.27× 1.40× 1.33× 1.14× 1.32×
Debt-to-Equity 0.73× 0.76× 0.88× 0.90× 0.76× 0.67×
Effective Tax Rate 23.37% 22.35% 23.51% 24.16% 23.64% 23.90%
Cash Conversion Ratio 1.25× 1.81× 1.77× 1.47× 0.89× 2.50×
Accruals Ratio -0.02× -0.06× -0.04× -0.02× 0.01× -0.11×
SBC % of Revenue 0.55% 0.63% 0.61% 0.64% 0.58% 0.57%
CapEx Coverage 1.83× 2.18× 1.70× 1.35× 1.03× 3.22×
Free Cash Flow Per Share $13.14 $16.49 $7.43 $3.50 $0.30 $19.00

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 9.44× 10.67× 14.90× 15.41× 10.97× 12.51×
P/FCF 16.60× 10.88× 20.52× 40.23× 430.91× 7.24×
FCF Yield 6.03% 9.19% 4.87% 2.49% 0.23% 13.82%
EV / EBITDA 7.36× 7.55× 9.18× 9.87× 8.11× 7.91×
P/S 0.81× 0.77× 0.75× 0.78× 0.86× 1.02×
P/B 1.93× 1.83× 1.74× 1.76× 1.78× 1.86×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 17.36B 15.83B 14.28B 13.40B 12.64B 11.56B
Operating Expenses 15.37B 14.15B 13.11B 12.40B 11.28B 10.20B
Operating Income (Loss) 1.99B 1.68B 1.18B 1.00B 1.36B 1.36B
Income Tax Expense (Benefit) 460.96M 334.83M 221.12M 209.28M 305.68M 299.29M
Net Income (Loss) Attributable to Parent 1.49B 1.14B 717.79M 675.61M 991.59M 943.95M
Earnings Per Share, Basic $23.42 $17.16 $10.35 $9.23 $11.99 $11.06
Weighted Average Number of Shares Outstanding, Basic 63.58M 66.55M 69.32M 73.12M 82.52M 85.06M
Earnings Per Share, Diluted $23.10 $16.82 $10.23 $9.14 $11.82 $10.99
Weighted Average Number of Shares Outstanding, Diluted 64.46M 67.90M 70.13M 73.83M 83.69M 85.59M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 137.80M 125.98M 119.44M 102.82M 115.30M 1.22B
Assets, Current 3.41B 2.82B 2.81B 2.54B 2.26B 3.28B
Assets 15.53B 14.47B 13.97B 13.49B 13.09B 13.48B
Long-term Debt 4.80B 4.50B 4.91B 4.81B 4.19B 3.86B
Liabilities, Current 3.24B 2.21B 2.01B 1.91B 1.98B 2.48B
Long-term Debt, Excluding Current Maturities 4.00B 4.46B 4.79B 4.73B 4.14B 3.52B
Stockholders' Equity Attributable to Parent 7.28B 6.67B 6.15B 5.92B 6.09B 6.32B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.86B 2.07B 1.27B 996.02M 883.70M 2.36B
Payments to Acquire Property, Plant, and Equipment 1.02B 943.81M 743.05M 734.00M 855.66M 731.31M
Net Cash Provided by (Used in) Investing Activities -1.07B -911.11M -763.27M -647.30M -914.47M -802.56M
Payments for Repurchase of Common Stock 967.95M 670.75M 547.36M 832.92M 1.22B 206.72M
Net Cash Provided by (Used in) Financing Activities -749.73M -1.14B -493.94M -318.40M -1.07B -384.86M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (UHS CIK 0000352915), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IRDM

Iridium Communications Inc.

SEVN

Seven Hills Realty Trust

BNTC

BENITEC BIOPHARMA INC.